Medicare Enrolled

Dr. Luis Melgar, MD

Internal Medicine · Depew, NY
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
4893 TRANSIT RD STE 3, Depew, NY 14043
7166087040
In practice since 2006 (20 years)
NPI: 1497701965 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Melgar from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Melgar? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Melgar

Dr. Luis Melgar is an internal medicine specialist in Depew, NY, with 20 years of NPI registration. Based on federal Medicare data, Dr. Melgar performed 454 Medicare services across 255 unique beneficiaries.

Between the years covered by Open Payments, Dr. Melgar received a total of $22,882 from 59 pharmaceutical and/or device companies across 1339 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in internal medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Melgar is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ 454 Medicare services $22,882 industry payments

Medicare Practice Summary

Medicare Utilization ↗
454
Medicare services
Bottom 44% in NY for internal medicine
255
Unique beneficiaries
$68
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~23 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
184 $58 $200
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
98 $53 $97
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
77 $79 $225
Hospital follow-up visit, high complexity
Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter.
55 $77 $135
Annual wellness visit, follow-up
A follow-up annual wellness visit that includes a personalized prevention plan of service.
40 $112 $298
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$22,882
Total received (2018-2024)
Avg $3,269/year across 7 years
Top 4% in NY for internal medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
59
Companies
1,339
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$22,405 (97.9%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$477 (2.1%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$3,920
2023
$3,511
2022
$3,997
2021
$3,358
2020
$2,870
2019
$2,973
2018
$2,253

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$671
GlaxoSmithKline, LLC.
$409
Regeneron Healthcare Solutions, Inc.
$341
PFIZER INC.
$322
CSL Behring
$243
Novo Nordisk Inc
$227
GENZYME CORPORATION
$226
Phathom Pharmaceuticals, Inc.
$208
Amgen Inc.
$205
Mylan Specialty L.P.
$190
Exact Sciences Corporation
$167
BioCryst US Sales Co., LLC
$114
Grifols USA, LLC
$86
Takeda Pharmaceuticals U.S.A., Inc.
$81
Lilly USA, LLC
$80
Genentech USA, Inc.
$67
Otsuka America Pharmaceutical, Inc.
$65
Pharming Healthcare, Inc.
$43
Lundbeck LLC
$40
Phadia US Inc.
$37
Novartis Pharmaceuticals Corporation
$37
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$35
Cycle Pharmaceuticals Inc
$14
Eisai Inc.
$13
Top 3 companies account for 36.2% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$3,337
GlaxoSmithKline, LLC.
$2,683
Novo Nordisk Inc
$1,611
PFIZER INC.
$1,511
Grifols USA, LLC
$1,343
CSL Behring
$1,299
Regeneron Healthcare Solutions, Inc.
$1,265
Amgen Inc.
$1,097
GENZYME CORPORATION
$947
Takeda Pharmaceuticals U.S.A., Inc.
$729
Lilly USA, LLC
$604
ALK-Abello, Inc
$474
Genentech USA, Inc.
$395
Shire North American Group Inc
$387
ABBVIE INC.
$384
Mylan Specialty L.P.
$348
Boehringer Ingelheim Pharmaceuticals, Inc.
$343
Teva Pharmaceuticals USA, Inc.
$338
BioCryst US Sales Co., LLC
$323
Otsuka America Pharmaceutical, Inc.
$303
Janssen Pharmaceuticals, Inc
$292
Exact Sciences Corporation
$219
kaleo, Inc.
$218
Phathom Pharmaceuticals, Inc.
$208
SANOFI-AVENTIS U.S. LLC
$203
OptiNose US, Inc.
$175
Amarin Pharma Inc.
$154
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$153
AbbVie Inc.
$141
Lundbeck LLC
$128
Kaleo, Inc.
$125
Biohaven Pharmaceuticals, Inc.
$113
Optinose US, Inc.
$92
Eisai Inc.
$88
Biohaven Pharmaceutical Holding Company Ltd.
$87
Greer Laboratories, Inc.
$80
Pharming Healthcare, Inc.
$75
Merck Sharp & Dohme Corporation
$61
Novartis Pharmaceuticals Corporation
$52
USWM, LLC
$48
Allergan, Inc.
$41
Aimmune Therapeutics, Inc.
$40
Phadia US Inc.
$37
Zyla Life Sciences, Inc.
$32
AIMMUNE THERAPEUTICS, INC.
$31
E.R. Squibb & Sons, L.L.C.
$30
Covis Pharma GmBH
$29
Sunovion Pharmaceuticals Inc.
$24
Abbott Laboratories
$21
RedHill Biopharma Inc.
$21
BioCryst Pharmaceuticals, Inc.
$21
Bio Products Laboratory USA, Inc.
$20
Horizon Therapeutics plc
$19
Kowa Pharmaceuticals America, Inc.
$17
Daiichi Sankyo Inc.
$16
Cycle Pharmaceuticals Inc
$14
Horizon Pharma plc
$13
Synergy Pharmaceuticals Inc
$12
ARBOR PHARMACEUTICALS, INC.
$11
Top 3 companies account for 33.4% of all-time payments
Associated products mentioned in payments ›
AIRSUPRA · AJOVY · ALVESCO · ANORO ELLIPTA · ARALAST · AREXVY · ASMANEX · AUVI-Q · Aimovig · AirDuo Digihaler · Auvi-Q · BASAGLAR · BEVESPI AEROSPHERE · BREO · BREO ELLIPTA · BREZTRI · BREZTRI AEROSPHERE · CHANTIX · CINQAIR · CINRYZE · CUVITRU · Cologuard Collection Kit · DUEXIS · DULERA · DUPIXENT · DUPIXENT DUPILUMAB INJECTION · Dayvigo · ELIQUIS · ENTRESTO · EUCRISA · FARXIGA · FASENRA · FIRAZYR · GAMMAGARD · Gammaplex · Gamunex-C · HYQVIA · Haegarda · Hizentra · Horizant · INJECTAFER · INVOKANA · ImmunoCAP · JANUVIA · JARDIANCE · KRYSTEXXA · Kcentra · LYRICA · Leqembi · Livalo · MOUNJARO · MOVANTIK · Movantik · NUCALA · NURTEC ODT · Neuromodulation Dspsbls and Accs · ORALAIR · ORLADEYO · Odactra · Orladeyo · Otezla · Ozempic · PALFORZIA · PANZYGA · PNEUMOVAX 23 · PRALUENT · PREMARIN · PREVNAR 20 · ProAir Digihaler · Prolastin-C Liquid · Prolia · QULIPTA · RELISTOR · REXULTI · RUCONEST · RYBELSUS · Rybelsus · SOLIQUA · SOLIQUA 100/33 · SPIRIVA · SPIRIVA RESPIMAT · SPRIX · STIOLTO RESPIMAT · SYMBICORT · SYMJEPI · Sajazir · Saxenda · TAKHZYRO · TEZSPIRE · TOUJEO · TRELEGY ELLIPTA · TRULICITY · Tresiba · Trulance · UBRELVY · UTIBRON · Uloric · VOQUEZNA · VRAYLAR · Vascepa · Victoza · Wegovy · XARELTO · XIFAXAN · Xembify · Xhance · Xofluza · Xolair · Xultophy 100/3.6 · YUPELRI · Yupelri · ZAVZPRET
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (98%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 4% for internal medicine in NY.

Looking for an internal medicine specialist in Depew?
Compare internal medicine physicians in the Depew area by procedure volume, costs, and industry payment transparency.
Browse internal medicine physicians nearby

Geographic Context

Internal medicine physicians within 10 mi
528
Per 100K population
55.6
County median income
$71,175
Nearest hospital
WESTERN NY CHILDRENS PSYCHIATRIC CENTER
4.9 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Melgar is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement in the top 4% of NY peers, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Melgar experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Melgar performed 184 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Melgar receive payments from pharmaceutical companies?
Yes. Dr. Melgar received a total of $22,882 from 59 companies across 1,339 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Melgar's costs compare to other internal medicine physicians in Depew?
Dr. Melgar's average Medicare payment per service is $68. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Melgar) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →